Shopping Cart
- Remove All
- Your shopping cart is currently empty
AMXI-5001 is a potent, orally active inhibitor of PARP1/2 and microtubule aggregation. AMXI-5001 shows selective anti-tumor cytotoxicity against a wide range of human cancer cells with IC50s well below those of existing clinical PARP1/2 inhibitors and induces complete regression of established tumors, including very large ones.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,620 | 6-8 weeks | |
50 mg | $2,110 | 6-8 weeks |
Description | AMXI-5001 is a potent, orally active inhibitor of PARP1/2 and microtubule aggregation. AMXI-5001 shows selective anti-tumor cytotoxicity against a wide range of human cancer cells with IC50s well below those of existing clinical PARP1/2 inhibitors and induces complete regression of established tumors, including very large ones. |
Molecular Weight | 457.46 |
Formula | C25H20FN5O3 |
Cas No. | 2170491-77-5 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.